Insider Holders & Insider Ownership - Seres Therapeutics Inc. (MCRB)

List of insiders holdings for Seres Therapeutics Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
NESTLE SA
Societe des Produits Nestle S.A.
10% Owner
2024-10-02 08:15:4921,781,753
0
21,781,753Form 13D
Nutritional Health LTP Fund General Partner LLC
Nutritional Health LTP Fund L.P.
Flagship Pioneering Inc.
AFEYAN NOUBAR
10% Owner
2022-07-07 17:00:240
17,617,352
17,617,352Form 4
AFEYAN NOUBAR
Flagship Ventures Fund 2007 L.P.
Flagship Ventures Fund IV L.P.
Flagship Ventures Fund IV-Rx L.P.
Flagship VentureLabs IV LLC
Flagship Ventures 2007 General Partner LLC
Flagship Ventures Fund IV General Partner LLC
KANIA EDWIN M JR
Director
10% Owner
2017-02-13 15:06:5612,682,876
0
12,682,876Form 13G
Flagship Ventures Fund IV General Partner LLC
Flagship Ventures Fund IV L.P.
Flagship Ventures Fund IV-Rx L.P.
Nutritional Health LTP Fund General Partner LLC
Nutritional Health LTP Fund L.P.
Flagship Pioneering Inc.
Flagship Pioneering Fund VI General Partner LLC
Flagship Pioneering Fund VI L.P.
AFEYAN NOUBAR
10% Owner
2020-11-25 18:00:450
11,018,191
11,018,191Form 4
Nestle Health Science US Holdings Inc.
NESTLE SA
NIMCO US Inc.
10% Owner
2022-07-22 13:34:007,594,038
0
7,594,038Form 13D
Flagship Pioneering Fund VII General Partner LLC
Flagship Pioneering Fund VII L.P.
10% Owner
2022-07-07 17:00:370
5,825,495
5,825,495Form 3
Arkowitz David
Chief Financial Officer
2024-02-16 21:13:51751,597
0
751,597Form 4
Thorell Marella
See Remarks
2024-03-27 16:20:09700,000
0
700,000Form 4
Aunins John G.
Chief Technology Officer & EVP
2020-01-31 16:05:20300,000
0
300,000Form 4
Shaff Eric D.
CEO and President
2024-11-19 16:15:09240,702
0
240,702Form 4
COOK DAVID N
See Remarks
2019-01-29 18:51:02159,935
0
159,935Form 4
DesRosier Thomas
Chief Legal Officer and EVP
2024-11-19 16:21:21159,099
0
159,099Form 4
Trucksis Michele
See Remarks
2018-01-30 20:58:24129,893
0
129,893Form 4
Berenson Stephen
Director
2024-07-03 16:15:05114,782
0
114,782Form 4
Young Teresa L.
See Remarks
2024-11-19 16:15:09114,311
0
114,311Form 4
Ege David S.
See Remarks
2024-08-19 17:29:45107,263
0
107,263Form 4
Henn Matthew R.
See Remarks
2024-11-19 16:15:04103,083
0
103,083Form 4
Hashad Wael
EVP & Chief Commercial Officer
2017-01-27 17:56:04100,000
0
100,000Form 4
Cloghessy Paula
See Remarks
2023-10-31 21:43:0473,936
0
73,936Form 4
Ausiello Dennis A
Director
2024-07-03 16:15:1364,564
0
64,564Form 4
Graves Kurt
Director
2024-07-03 16:15:0664,564
0
64,564Form 4
Dere Willard H
Director
2024-04-08 16:45:1260,000
0
60,000Form 4
Kender Richard N
Director
2024-04-08 16:45:1860,000
0
60,000Form 4
Biondi Paul
Director
2024-04-08 16:45:1660,000
0
60,000Form 4
Fraser Claire
Director
2024-04-08 16:45:1560,000
0
60,000Form 4
von Moltke Lisa
See Remarks
2024-11-19 16:20:0659,134
0
59,134Form 4
Chapman Marcus
See Remarks
2021-02-08 18:55:0236,000
0
36,000Form 4
Behar Gregory
Director
2023-06-23 17:24:2835,000
0
35,000Form 4
Zausner Meryl
Director
2022-07-06 19:19:5231,746
0
31,746Form 4
HORGAN KEVIN
Chief Medical Officer and EVP
2019-01-29 18:55:3630,000
0
30,000Form 4
HUTT PETER BARTON
Director
2016-06-17 18:32:4615,000
0
15,000Form 4
Pomerantz Roger
Director
2019-06-14 16:19:0615,000
0
15,000Form 4
Kim Lorence H.
Director
2019-06-14 16:19:3315,000
0
15,000Form 4
CAUTREELS WERNER
Director
2015-06-29 18:10:0615,000
0
15,000Form 4